Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2005
08/30/2005US6936258 Staphylococcus antigen and vaccine
08/30/2005US6936251 Detection using antibodies
08/30/2005US6936249 Proteins producing an altered immunogenic response and methods of making and using the same
08/30/2005US6936248 Methods of inhibiting GPR-9-6 function
08/30/2005US6936247 Filariid anti-P22U antibodies
08/30/2005US6936246 Passive immunization of ASCR for prion disorders
08/30/2005US6936225 Apparatus for use in medical evaluation of fluid samples and diagnosis human defects
08/30/2005US6936156 Ion selective electrodes; rinsing, gas purging
08/30/2005US6936150 Methods and apparatus for electrophoresis of prior-cast, hydratable separation media
08/30/2005US6936147 Hybrid film type sensor
08/30/2005US6936146 Electrochemical biosensor readout meter
08/30/2005US6936013 Intra-vaginal self-administered cell collecting device and method
08/30/2005US6935552 High-precision method and apparatus for evaluating creep damage
08/30/2005US6935311 Engine control with fuel quality sensor
08/30/2005US6935197 Method and apparatus for testing uncured prepreg material
08/30/2005US6935165 Microscale sensor element and related device and method of use
08/30/2005US6935159 Centrifugal permeameter
08/30/2005US6935158 MIS hydrogen sensors
08/30/2005CA2294647C Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor
08/30/2005CA2294566C Ikk-.alpha. proteins, nucleic acids and methods
08/30/2005CA2217113C Method for testing and determining the alloy class of an aluminum alloy
08/30/2005CA2212043C Method for assay of analyte by adjustment of chemiluminescence
08/30/2005CA2202879C Calcium receptor-active compounds
08/30/2005CA2157873C Breath collection
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/30/2005CA1341488C Precursor antigens for human retorvirus (hiv-2) envelope glycoproteins, and immunologically related antigens
08/27/2005CA2459121A1 Dynamic hormone index as a biomarker for disease
08/26/2005CA2458921A1 Displacement method of knot sizing
08/25/2005WO2005078456A1 Method for detecting the formation of endothelins for medical diagnosis, and antibodies and kits for carrying out one such method
08/25/2005WO2005078455A1 Diagnostics and therapeutics for diseases associated with human melatonin receptor type 1a (mtnr1a)
08/25/2005WO2005078454A2 Methods for determining the amount of peptide yy in blood
08/25/2005WO2005078453A2 Proteome epitope tags and methods of use thereof in protein modification analysis
08/25/2005WO2005078452A1 Methods and apparatus for identifying patients at risk for life threatening arrhythmias
08/25/2005WO2005078451A1 Method for peptide analysis
08/25/2005WO2005078450A2 Method for the detection of early b cell populations in vaccine development
08/25/2005WO2005078449A1 Method and kit for identifying the function of gene product and identifying binding substance
08/25/2005WO2005078448A1 Apparatus for assessing degree of fatigue, method of assessing degree of fatigue and use thereof
08/25/2005WO2005078447A1 Method of analyzing c-terminal amino acid sequence of peptide
08/25/2005WO2005078446A1 Method for a rapid test
08/25/2005WO2005078445A1 Non-invasive real-time in vivo bioluminescence imaging of local ca2+ dynamics in living organisms
08/25/2005WO2005078444A1 Diagnostics and therapeutics for diseases associated with human melatonin receptor type 1b (mtnr1b)
08/25/2005WO2005078443A1 Determination of infection by the immune response to a carbohydrate moiety
08/25/2005WO2005078442A1 Comprehensive food allergy test
08/25/2005WO2005078441A1 Sampling device, the method and use thereof
08/25/2005WO2005078440A2 Preparation of biologically derived fluids for biomarker determination by mass spectrometry
08/25/2005WO2005078439A2 Wound meter
08/25/2005WO2005078438A2 Use of two-photon excited fluorescence in assays of clinical chemistry analytes
08/25/2005WO2005078437A1 Electrochemical biosensor
08/25/2005WO2005078436A1 Fluid testing sensor having vents for directing fluid flow
08/25/2005WO2005078435A1 Method and system for determining the modulus of elasticity of green lumber
08/25/2005WO2005078434A2 Methods for forming palladium alloy thin films and optical hydrogen sensors employing palladium alloy thin films
08/25/2005WO2005078433A1 Method and device for producing fragrance and/or aroma compositions
08/25/2005WO2005078427A1 Device for instantaneous and continuous measurement of substances in an aqueous phase
08/25/2005WO2005078420A1 Measuring method and device for carrying out a differential microcalorimetric analysis of a material capable of containing crystals
08/25/2005WO2005078412A1 Gas composition monitoring arrangement
08/25/2005WO2005078411A1 Method for determining clinical and/or chemical parameters in a medium and device for carrying out said method
08/25/2005WO2005078408A1 A method of determining a modulus of elasticity of a moving web material
08/25/2005WO2005078384A1 Device for the optical analysis, including two-dimensional, of a thread or yarn
08/25/2005WO2005078137A1 Methods and apparati using single polymer analysis
08/25/2005WO2005078126A2 Means for detecting and treating cancer cells resistant to therapeutic agents
08/25/2005WO2005078124A2 Diagnostic marker for cancer
08/25/2005WO2005078119A1 Probe for detecting nuclear receptor agonist or antagonist and method of screening agonist or antagonist to nuclear receptor with the use of the same
08/25/2005WO2005078117A2 Diagnostics and therapeutics for diseases associated with kallikrein 6 (klk6)
08/25/2005WO2005078106A1 Orotate transporter encoding marker genes
08/25/2005WO2005078091A1 Induction of apoptosis by inhibition of sirtuin sirt1 expression
08/25/2005WO2005078087A1 Antibody targeting osteoclast-associated protein
08/25/2005WO2005078083A1 Ultra-smooth microfabricated pores on a planar substrate for integrated patch-clamping
08/25/2005WO2005078082A1 Method of constructing probe dna for nucleic acid encoding membrane protein, method of detecting the expression of gene encoding membrane protein and probe dna immobilization support
08/25/2005WO2005078076A2 Tpl2 and its expression
08/25/2005WO2005077978A2 Antibody for diagnosing and treating neuropsychiatric diseases, in particular schizophrenia, depression and bipolar affective disorders
08/25/2005WO2005077965A1 Sugar chain ligand composite and method of analyzing protein with the ligand composite
08/25/2005WO2005077299A1 Isolated plasma and method for hyperimmunisation and plasma collection
08/25/2005WO2005077106A2 Monoclonal antibody based biomarker discovery and development platform
08/25/2005WO2005077090A2 Improved methods of producing antibody conjugates
08/25/2005WO2005077084A2 Krüppel-like transcriptional factor klf4/gklf and uses thereof
08/25/2005WO2005077065A2 Selective high-affinity polydentate ligands and methods of making such
08/25/2005WO2005077040A2 Compositions and methods for treating amyotrophic lateral sclerosis (als)
08/25/2005WO2005077007A2 Methods of diagnosing and treating pre-eclampsia or eclampsia
08/25/2005WO2005076995A2 Method of measurement of nucleated red blood cells
08/25/2005WO2005076984A2 Thymidylate synthase gene and metastasis
08/25/2005WO2005076979A2 Diagnosis and therapeutics for cancer
08/25/2005WO2005076893A2 Compositions and methods for determining the replication capacity of a pathogenic virus
08/25/2005WO2005076891A2 Cell proliferation associated with ccx ckr expression
08/25/2005WO2005076887A2 Methods and systems for sampling, screening, and diagnosis
08/25/2005WO2005076861A2 Compounds that inhibit hiv particle formation
08/25/2005WO2005076785A2 Method and compositions for detecting botulinum neurotoxin
08/25/2005WO2005076781A2 System and method for explosives detection
08/25/2005WO2005062952A3 Compositions and methods for modulating sirtuin activity
08/25/2005WO2005062918A3 Methods of treating asthma
08/25/2005WO2005059562A3 Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases
08/25/2005WO2005059558A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor mc4 (mc4)
08/25/2005WO2005056599A3 Antibodies that specifically bind pms2
08/25/2005WO2005056584A3 Novel strain of sars-associated coronavirus and applications thereof
08/25/2005WO2005054863A3 Diagnostics and therapeutics for diseases associated with g protein-coupled inwardly rectifying potassium channel (girk 3)
08/25/2005WO2005054431A9 Method for isolation of independent, parallel chemical micro-reactions using a porous filter
08/25/2005WO2005051995A3 Novel advanced glycosylation end product-specific receptor-like protein and nucleic acids encoding same
08/25/2005WO2005049590A3 N-sulfonylaminocarbonyl containing compounds
08/25/2005WO2005047320A3 Equine p-selection glycoprotein ligand-1 and uses thereof
08/25/2005WO2005045433A3 Method for distinguishing aml subtypes with aberrant and prognostically intermediate karyotypes
08/25/2005WO2005043170A3 Ubiquitin-based protein interaction assays and related compositions
1 ... 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 ... 3937